Impact of rotavirus vaccination
In Europe, routine rotavirus vaccination of infants at the national level has been introduced with one or two vaccine brands in Finland, Austria, Luxembourg and Belgium within well-baby clinics or administered by general practitioners and paediatricians. When introducing a new vaccine, it is crucial to conduct studies evaluating the vaccination’s impact and effectiveness in order to decide on recommendations for its future use. To this end, ECDC has produced three generic protocols: a protocol for developing cohort studies to assess the effectiveness of the rotavirus vaccination in EU Members States; a protocol proposing prospective case control study designs to estimate rotavirus vaccine effectiveness; and a protocol for developing studies to assess the impact of rotavirus vaccination EU Member States.
HEPSA – health emergency preparedness self-assessment tool, User guide
20 Jun 2018 - HEPSA is used to evaluate levels of preparedness, identify potential gaps, identify vulnerabilities, and detect areas for improvement – with the goal to strengthen overall preparedness capacities for public health emergencies. This user guide provides basic information on the self-assessment process.
European Legionnaires’ Disease Surveillance Network (ELDSNet) - Operating procedures
15 Dec 2017 - This document explains the operating procedures of the European Legionnaires’ Disease Surveillance Network, coordinated by ECDC. It specifically relates to reporting cases of travel-associated Legionnaires’ disease arising from stays in hotel or other commercial holiday accommodation. The aim is to quickly identify and control outbreaks of the disease and minimise the risk to holidaymakers. This edition supersedes the January 2012 edition.